More information about ANTERIS TECHS LTD. AMEUF

Admedus is a global healthcare company that develops, commercialises and distributes next generation medical technologies and devices. The healthcare company is listed on the Australian Stock Exchange under the code: AHZ. Admedus has four core healthcare divisions. - Tissue Engineering – Using our proprietary ADAPT® engineering process we are developing a suite of regenerative tissue bio-scaffolds to be used in soft tissue repairs. We are also focused on the expansion of our lead regenerative tissue product CardioCel®. - Immunotherapies– Working with immunologist Professor Ian Frazer and his team, we are developing next generation vaccines for the treatment and prevention of infectious diseases and cancers with an initial focus on Herpes Simplex Virus (HSV-2) and Human papillomavirus (HPV). Sales and Distribution – Our medical products team is responsible for distributing a range of infusion solutions to hospitals in Australia and New Zealand, and our tissue products globally. View products… Bio-manufacturing – Admedus has a state-of-the-art manufacturing facility in Australia that is used for the global production of CardioCel® and R&D projects. Read more…